Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Valsartan Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110078640B reveals a salt-effect method for valsartan intermediate synthesis, enhancing purity and yield while reducing acid chloride hydrolysis for cost-effective manufacturing.
Patent CN115197096A reveals a high-yield catalytic method for valsartan intermediates, eliminating dimer impurities and enabling cost-effective pharmaceutical manufacturing.
Novel patent CN115197096B offers high-yield valsartan intermediate synthesis. Reduces dimer impurities, ensures supply chain stability for pharmaceutical manufacturing.